The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $3.15 billion in 2025 to $3.54 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growth in preclinical research activities, increasing drug discovery investments, expansion of academic research funding, rising use of animal models in disease studies, availability of advanced imaging modalities.
The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $5.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine research tools, rising investments in translational research, expansion of oncology and neurological studies, growing adoption of ai-assisted diagnostics, increasing focus on real-time biological imaging. Major trends in the forecast period include increasing adoption of multimodal imaging systems, rising use of non-invasive in vivo imaging techniques, growing integration of ai-based image analysis, expansion of longitudinal disease monitoring studies, enhanced focus on high-resolution imaging capabilities.
Increasing healthcare sector spending is anticipated to support the expansion of the small animal imaging (in vivo) market in the coming years. Healthcare expenditure represents the total spending on health services, including both public and private outlays, expressed as a share of gross domestic product. Higher healthcare spending, along with growing awareness of health management, is promoting the adoption of self-care and advanced diagnostic approaches, where positron emission tomography systems are applied in methods such as small animal imaging. In vivo small animal imaging benefits the healthcare ecosystem by enabling noninvasive, real-time visualization of biological processes, accelerating drug discovery timelines, enhancing disease understanding, and supporting the development of more effective therapeutic solutions. For example, in May 2024, a report released by the Office for National Statistics, a United Kingdom-based government statistical authority, indicated that healthcare expenditure in the United Kingdom rose by 5.6% in nominal terms in 2023, while long-term health and social care spending increased by 2.8% in real terms in 2022. As a result, rising healthcare expenditure is contributing to the growth of the small animal imaging (in vivo) market.
Leading companies operating in the small animal imaging (in vivo) space are increasingly emphasizing advanced imaging software solutions, including real-time kinetic analysis capabilities, to address the growing demand for highly accurate, quantitative, and high-throughput preclinical research in areas such as oncology and neuroscience. These software solutions enable continuous acquisition and automated evaluation of dynamic bioluminescent signals over time, moving beyond conventional static single-timepoint imaging and generating more comprehensive kinetic profiles, improved reproducibility, and enhanced detection of peak signal phases. For instance, in April 2024, Spectral Instruments Imaging, a United States-based provider of preclinical imaging technologies, introduced Aura 4.5, the newest release of its in vivo imaging software. Aura 4.5 features a Kinetics mode that supports automated, real-time capture of bioluminescent signals across their entire temporal progression, including rise, plateau, and decay phases. The platform automatically determines and reports peak signal intensity, enabling researchers to achieve greater sensitivity and biological precision. In addition, the update simplifies data collection and minimizes manual handling, improving operational efficiency for longitudinal and time-critical studies such as pharmacokinetic analyses, gene expression research, and infection models.
In February 2024, Bruker Corporation, a US-based biotechnology research company, acquired Spectral Instruments Imaging for an undisclosed sum. This acquisition is intended to bolster Bruker Corporation's imaging technology capabilities, particularly in advanced imaging systems for life sciences and materials research. The integration of Spectral Instruments Imaging's expertise in specialized imaging solutions will enhance Bruker's offerings in this area. Spectral Instruments Imaging is a US-based company known for its advanced imaging solutions.
Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation.
North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the small animal imaging (in-vivo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the small animal imaging (in-vivo) market by increasing costs of imported imaging detectors, scanners, contrast agents, electronic components, and precision optics. Research institutions and pharmaceutical laboratories in North America and Europe are most affected due to reliance on advanced imported imaging systems, while Asia-Pacific faces cost pressures on system procurement. These tariffs are increasing capital investment requirements and delaying equipment upgrades. At the same time, they are supporting regional manufacturing partnerships, localized system assembly, and domestic innovation in preclinical imaging technologies.
The small animal imaging (in-vivo) market research report is one of a series of new reports that provides small animal imaging (in-vivo) market statistics, including small animal imaging (in-vivo) industry global market size, regional shares, competitors with a small animal imaging (in-vivo) market share, detailed small animal imaging (in-vivo) market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging (in-vivo) industry. This small animal imaging (in-vivo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Small animal imaging (in vivo) pertains to advanced imaging techniques designed for monitoring cellular activity, pharmacological effects, and disease progression in live animals. It enables the observation, definition, and quantification of normal and pathologic processes in living animal organs and tissues in a non-invasive manner.
Key components of small animal imaging (in vivo) include micro-MRI, optical imaging, nuclear imaging, and other elements. Micro-MRI, a non-invasive technique, produces detailed three-dimensional (3D) images of tissues without exposing the subject to harmful radiation. This approach finds various applications, such as monitoring treatment response, assessing biodistribution, determining drug/target engagement, detecting cancer cells, exploring biomarkers, conducting longitudinal studies, and investigating epigenetics. These applications are employed in veterinary clinics, veterinary hospitals, as well as veterinary institutes and research centers.
The small animal imaging (in-vivo) market includes revenues earned by PET, X-ray CT, MRI, and SPECT scanners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $5.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine research tools, rising investments in translational research, expansion of oncology and neurological studies, growing adoption of ai-assisted diagnostics, increasing focus on real-time biological imaging. Major trends in the forecast period include increasing adoption of multimodal imaging systems, rising use of non-invasive in vivo imaging techniques, growing integration of ai-based image analysis, expansion of longitudinal disease monitoring studies, enhanced focus on high-resolution imaging capabilities.
Increasing healthcare sector spending is anticipated to support the expansion of the small animal imaging (in vivo) market in the coming years. Healthcare expenditure represents the total spending on health services, including both public and private outlays, expressed as a share of gross domestic product. Higher healthcare spending, along with growing awareness of health management, is promoting the adoption of self-care and advanced diagnostic approaches, where positron emission tomography systems are applied in methods such as small animal imaging. In vivo small animal imaging benefits the healthcare ecosystem by enabling noninvasive, real-time visualization of biological processes, accelerating drug discovery timelines, enhancing disease understanding, and supporting the development of more effective therapeutic solutions. For example, in May 2024, a report released by the Office for National Statistics, a United Kingdom-based government statistical authority, indicated that healthcare expenditure in the United Kingdom rose by 5.6% in nominal terms in 2023, while long-term health and social care spending increased by 2.8% in real terms in 2022. As a result, rising healthcare expenditure is contributing to the growth of the small animal imaging (in vivo) market.
Leading companies operating in the small animal imaging (in vivo) space are increasingly emphasizing advanced imaging software solutions, including real-time kinetic analysis capabilities, to address the growing demand for highly accurate, quantitative, and high-throughput preclinical research in areas such as oncology and neuroscience. These software solutions enable continuous acquisition and automated evaluation of dynamic bioluminescent signals over time, moving beyond conventional static single-timepoint imaging and generating more comprehensive kinetic profiles, improved reproducibility, and enhanced detection of peak signal phases. For instance, in April 2024, Spectral Instruments Imaging, a United States-based provider of preclinical imaging technologies, introduced Aura 4.5, the newest release of its in vivo imaging software. Aura 4.5 features a Kinetics mode that supports automated, real-time capture of bioluminescent signals across their entire temporal progression, including rise, plateau, and decay phases. The platform automatically determines and reports peak signal intensity, enabling researchers to achieve greater sensitivity and biological precision. In addition, the update simplifies data collection and minimizes manual handling, improving operational efficiency for longitudinal and time-critical studies such as pharmacokinetic analyses, gene expression research, and infection models.
In February 2024, Bruker Corporation, a US-based biotechnology research company, acquired Spectral Instruments Imaging for an undisclosed sum. This acquisition is intended to bolster Bruker Corporation's imaging technology capabilities, particularly in advanced imaging systems for life sciences and materials research. The integration of Spectral Instruments Imaging's expertise in specialized imaging solutions will enhance Bruker's offerings in this area. Spectral Instruments Imaging is a US-based company known for its advanced imaging solutions.
Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation.
North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the small animal imaging (in-vivo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the small animal imaging (in-vivo) market by increasing costs of imported imaging detectors, scanners, contrast agents, electronic components, and precision optics. Research institutions and pharmaceutical laboratories in North America and Europe are most affected due to reliance on advanced imported imaging systems, while Asia-Pacific faces cost pressures on system procurement. These tariffs are increasing capital investment requirements and delaying equipment upgrades. At the same time, they are supporting regional manufacturing partnerships, localized system assembly, and domestic innovation in preclinical imaging technologies.
The small animal imaging (in-vivo) market research report is one of a series of new reports that provides small animal imaging (in-vivo) market statistics, including small animal imaging (in-vivo) industry global market size, regional shares, competitors with a small animal imaging (in-vivo) market share, detailed small animal imaging (in-vivo) market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging (in-vivo) industry. This small animal imaging (in-vivo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Small animal imaging (in vivo) pertains to advanced imaging techniques designed for monitoring cellular activity, pharmacological effects, and disease progression in live animals. It enables the observation, definition, and quantification of normal and pathologic processes in living animal organs and tissues in a non-invasive manner.
Key components of small animal imaging (in vivo) include micro-MRI, optical imaging, nuclear imaging, and other elements. Micro-MRI, a non-invasive technique, produces detailed three-dimensional (3D) images of tissues without exposing the subject to harmful radiation. This approach finds various applications, such as monitoring treatment response, assessing biodistribution, determining drug/target engagement, detecting cancer cells, exploring biomarkers, conducting longitudinal studies, and investigating epigenetics. These applications are employed in veterinary clinics, veterinary hospitals, as well as veterinary institutes and research centers.
The small animal imaging (in-vivo) market includes revenues earned by PET, X-ray CT, MRI, and SPECT scanners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Small Animal Imaging (in-Vivo) Market Characteristics
3. Small Animal Imaging (in-Vivo) Market Supply Chain Analysis
4. Global Small Animal Imaging (in-Vivo) Market Trends and Strategies
5. Small Animal Imaging (in-Vivo) Market Analysis of End Use Industries
7. Global Small Animal Imaging (in-Vivo) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Small Animal Imaging (in-Vivo) Total Addressable Market (TAM) Analysis for the Market
9. Small Animal Imaging (in-Vivo) Market Segmentation
10. Small Animal Imaging (in-Vivo) Market Regional and Country Analysis
11. Asia-Pacific Small Animal Imaging (in-Vivo) Market
12. China Small Animal Imaging (in-Vivo) Market
13. India Small Animal Imaging (in-Vivo) Market
14. Japan Small Animal Imaging (in-Vivo) Market
15. Australia Small Animal Imaging (in-Vivo) Market
16. Indonesia Small Animal Imaging (in-Vivo) Market
17. South Korea Small Animal Imaging (in-Vivo) Market
18. Taiwan Small Animal Imaging (in-Vivo) Market
19. South East Asia Small Animal Imaging (in-Vivo) Market
20. Western Europe Small Animal Imaging (in-Vivo) Market
21. UK Small Animal Imaging (in-Vivo) Market
22. Germany Small Animal Imaging (in-Vivo) Market
23. France Small Animal Imaging (in-Vivo) Market
24. Italy Small Animal Imaging (in-Vivo) Market
25. Spain Small Animal Imaging (in-Vivo) Market
26. Eastern Europe Small Animal Imaging (in-Vivo) Market
27. Russia Small Animal Imaging (in-Vivo) Market
28. North America Small Animal Imaging (in-Vivo) Market
29. USA Small Animal Imaging (in-Vivo) Market
30. Canada Small Animal Imaging (in-Vivo) Market
31. South America Small Animal Imaging (in-Vivo) Market
32. Brazil Small Animal Imaging (in-Vivo) Market
33. Middle East Small Animal Imaging (in-Vivo) Market
34. Africa Small Animal Imaging (in-Vivo) Market
36. Small Animal Imaging (in-Vivo) Market Competitive Landscape and Company Profiles
37. Small Animal Imaging (in-Vivo) Market Other Major and Innovative Companies
40. Small Animal Imaging (in-Vivo) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Small Animal Imaging (In-Vivo) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses small animal imaging (in-vivo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for small animal imaging (in-vivo)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small animal imaging (in-vivo) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Micro-MRI; Optical Imaging; Nuclear Imaging; Other Components2) By Application: Monitoring Treatment Response; Bio Distribution, Determining Drug or Target Engagement; Cancer Cell Detection; Biomarkers; Longitudinal Studies; Epigenetics
3) By End User: Veterinary Clinics; Veterinary Hospitals; Veterinary Institutes and Research Centers
Subsegments:
1) By Micro-MRI: High-Field Micro-MRI Systems; Low-Field Micro-MRI Systems; MRI Contrast Agents2) By Optical Imaging: In Vivo Fluorescence Imaging Systems; Bioluminescence Imaging Systems; Optical Coherence Tomography Systems
3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners; Single Photon Emission Computed Tomography (SPECT) Systems; Radioactive Tracers
4) By Other Components: X-Ray Imaging Systems; CT Imaging Systems; Ultrasound Imaging Systems
Companies Mentioned: Bruker Corporation; PerkinElmer Inc.; Mediso Ltd.; Aspect Imaging Ltd.; Spectral Instruments Imaging LLC; Bioscan Inc.; Gamma Medica-Ideas Inc.; LI-COR Biosciences; Scanco Medical AG; TriFoil Imaging Inc.; MR Solutions Ltd.; MILabs B.V.; Trifoil Imaging Inc.; VisualSonics Inc.; Fujifilm VisualSonics Inc.; Sedecal S.A.; Kubtec Medical Imaging; Carestream Health Inc.; Thermo Fisher Scientific Inc.; Rigaku Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Small Animal Imaging (in-Vivo) market report include:- Bruker Corporation
- PerkinElmer Inc.
- Mediso Ltd.
- Aspect Imaging Ltd.
- Spectral Instruments Imaging LLC
- Bioscan Inc.
- Gamma Medica-Ideas Inc.
- LI-COR Biosciences
- Scanco Medical AG
- TriFoil Imaging Inc.
- MR Solutions Ltd.
- MILabs B.V.
- Trifoil Imaging Inc.
- VisualSonics Inc.
- Fujifilm VisualSonics Inc.
- Sedecal S.A.
- Kubtec Medical Imaging
- Carestream Health Inc.
- Thermo Fisher Scientific Inc.
- Rigaku Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.54 Billion |
| Forecasted Market Value ( USD | $ 5.53 Billion |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
